Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Summary - MDSpire

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • By

  • Chengqian Chen

  • Wei Guo

  • Xiaoyu Song

  • Xin Wan

  • Zhaoxia Li

  • Haotian Wang

  • Ou Bai

  • May 29, 2026

  • 0 min

Share

Objective:

Revise to remove unsupported claims about the shift in treatment approaches.

Key Findings:
  • Remove phrases like 'reshaped treatment strategies' unless directly quoted.
Interpretation:

Remove or rephrase to reflect only what is stated in the source.

Limitations:
  • Ensure limitations are directly sourced or paraphrased from the original text.
Conclusion:

Revise to reflect only the source material without unsupported claims.

Original Source(s)

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • by Chengqian Chen, Wei Guo, Xiaoyu Song, Xin Wan, Zhaoxia Li, Haotian Wang, Ou Bai

  • May 29, 2026

Related Content

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms